Next Article in Journal
Prediction of One-Year Mortality Based upon A New Staged Mortality Risk Model in Patients with Aortic Stenosis Undergoing Transcatheter Valve Replacement
Next Article in Special Issue
Cardiac Imaging in Liver Transplantation Candidates: Current Knowledge and Future Perspectives
Previous Article in Journal
Management Strategies for Antidepressant-Related Sexual Dysfunction: A Clinical Approach
Previous Article in Special Issue
Biatrial Remodeling in Patients with Cystic Fibrosis
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

More Impaired Dynamic Ventilatory Muscle Oxygenation in Congestive Heart Failure than in Chronic Obstructive Pulmonary Disease

1
Division of Pulmonary Medicine and Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung 40201, Taiwan
2
School of Medicine, Chung Shan Medical University, Taichung 40201, Taiwan
3
Institute and Department of Public Health, National Yang Ming University, Taipei 11221, Taiwan
4
Department of Pulmonary and Critical Care Medicine, Chiayi Chang-Gung Memorial Hospital, Chang-Gung Medical Foundation, Chiayi 61363, Taiwan
5
Department of Respiratory Therapy, Chang Gung University, Taoyuan 33302, Taiwan
*
Author to whom correspondence should be addressed.
J. Clin. Med. 2019, 8(10), 1641; https://doi.org/10.3390/jcm8101641
Submission received: 11 September 2019 / Revised: 30 September 2019 / Accepted: 2 October 2019 / Published: 7 October 2019

Abstract

:
Patients with chronic obstructive pulmonary disease (COPD) and congestive heart failure (CHF) often have dyspnea. Despite differences in primary organ derangement and similarities in secondary skeletal muscle changes, both patient groups have prominent functional impairment. With similar daily exercise performance in patients with CHF and COPD, we hypothesized that patients with CHF would have worse ventilatory muscle oxygenation than patients with COPD. This study aimed to compare differences in tissue oxygenation and blood capacity between ventilatory muscles and leg muscles and between the two patient groups. Demographic data, lung function, and maximal cardiopulmonary exercise tests were performed in 134 subjects without acute illnesses. Muscle oxygenation and blood capacity were measured using frequency-domain near-infrared spectroscopy (fd-NIRS). We enrolled normal subjects and patients with COPD and CHF. The two patient groups were matched by oxygen-cost diagram scores, New York Heart Association functional classification scores, and modified Medical Research Council scores. COPD was defined as forced expired volume in one second and forced expired vital capacity ratio ≤0.7. CHF was defined as stable heart failure with an ejection fraction ≤49%. The healthy subjects were defined as those with no obvious history of chronic disease. Age, body mass index, cigarette consumption, lung function, and exercise capacity were different across the three groups. Muscle oxygenation and blood capacity were adjusted accordingly. Leg muscles had higher deoxygenation (HHb) and oxygenation (HbO2) and lower oxygen saturation (SmO2) than ventilatory muscles in all participants. The SmO2 of leg muscles was lower than that of ventilatory muscles because SmO2 was calculated as HbO2/(HHb+HbO2), and the HHb of leg muscles was relatively higher than the HbO2 of leg muscles. The healthy subjects had higher SmO2, the patients with COPD had higher HHb, and the patients with CHF had lower HbO2 in both muscle groups throughout the tests. The patients with CHF had lower SmO2 of ventilatory muscles than the patients with COPD at peak exercise (p < 0.01). We conclud that fd-NIRS can be used to discriminate tissue oxygenation of different musculatures and disease entities. More studies on interventions on ventilatory muscle oxygenation in patients with CHF and COPD are warranted.

1. Introduction

Exercise intolerance and exertional dyspnea are often encountered in patients with chronic obstructive pulmonary disease (COPD) and cardiovascular diseases, and especially in those with congestive heart failure (CHF) [1]. The symptoms are primarily caused by heart and lung pathological changes that lead to physiological limitations, and secondarily by ventilatory and locomotor muscle weakness due to myopathy [1,2,3,4]. Causes of myopathy include hypoxia, oxidative stress, medication, nutritional depletion, systemic inflammation, disuse and atrophy (sarcopenia). However, functional impairment is more prominent than structural derangement. It has been hypothesized that functional impairment is further impaired by exercise due to failure of perfusion to meet the need of increased metabolism. Patients with CHF have primarily reduced central cardiovascular function, whereas patients with COPD have secondarily reduced central cardiovascular function caused by dynamic hyperinflation [5]. Moreover, the locomotor muscles are expected to be more impaired than the inspiratory muscles (diaphragm), as inspiratory muscles are more resistant to fatigue with a higher proportion of type I fibers, despite also being impaired in strength, whereas the quadriceps have a lower proportion of type I fibers [6,7,8]. Even though the mechanisms of myopathy, muscle morphology, muscle fiber type distribution and shifting, and muscle metabolism in the locomotor muscles are similar in patients with COPD and CHF [1,9], exercise-induced hypoxemia, if it occurs, is expected to aggravate hypoxic stress in patients with COPD, as the patterns of muscle cytochrome oxidase gene activation are altered in these patients [8]. In addition, hypoxemia may cause an increase in myostatin protein expression, which is related to muscle atrophy [10], and patients with COPD can experience vascular dysfunction with a higher extraction of muscle oxygen during exercise even in the early stage [11]. Therefore, it is not clear whether there are differences in the functions of locomotor and ventilatory muscles between patients with COPD and CHF who have similar daily exercise performance and dyspnea sensation.
Muscle function depends primarily on perfusion, muscle mass, fiber composition, and energy metabolism [1]. However, clinically, measurements of pressure, electromyography, and motor unit firing rates for ventilatory muscles [7], and strength and endurance for locomotor muscles [12], muscle oxygenation and perfusion measurements may be alternative methods to assess muscle function [13,14,15,16,17], and they have been reported to potentially be superior to the transdiaphragmatic tension time index [18]. Combining the indocyanine green dye (IGD) technique and near infrared spectroscopy (NIRS) has been reported to improve measurements of the peripheral muscle blood flow in healthy subjects and patients with COPD [19,20,21,22]. However, the IGD technique is sophisticated and its invasiveness related to the need to obtain arterial blood samples means that it is not widely used clinically. Subsequently, a relatively minimally invasive modified NIRS and IGD method to measure blood flow index was developed. The blood flow index has been shown to be highly correlated with muscle blood flow in ventilatory muscles and leg muscles in healthy subjects and patients with COPD [23,24,25]. However, the absolute blood flow cannot be determined using the blood flow index method.
With advances in NIRS technology, frequency-domain NIRS (fdNIRS) is capable of providing absolute values rather than relative changes in value [26]. This improvement allows for direct comparisons of oxygenation in different musculatures and different groups of subjects. Therefore, using fdNIRS, this study aimed to investigate differences in the balance of offering and utilizing oxygenation in leg and ventilatory musculature in non-obese healthy subjects and patients with COPD and CHF. This is the first study to compare the oxygenation of ventilatory and leg muscles between patients with COPD and CHF who have similar daily physical activity.

2. Methods

2.1. Study Design

In this observational study, we compared oxygenation and perfusion in two local musculatures during exercise as measured by near infrared spectroscopy (NIRS) across three groups of participants (healthy subjects, patients with COPD, and patients with CHF). The local Institutional Review Boards of Chung Shan Medical University Hospital (CS11144 and CMRPG32058) approved this study, which was conducted in compliance with the Declaration of Helsinki. Signed informed consent was obtained from each participant. The study was registered at Chung Shan Medical University Hospital (CSH-2012-C-23).

2.2. Subjects

Adult subjects were screened, enrolled, and allocated into COPD, CHF, and control groups from two university hospitals in Taiwan if they agreed to participate in the study. COPD was defined according to the GOLD guideline as follows [27]: a history of cigarette smoking for ≥10 pack-years; forced expired volume in one second and forced expired vital capacity ratio (FEV1/FVC) ≤0.7, and no significant bronchodilation in a stable condition. Stable CHF was defined as stable heart failure with a mid-range or reduced ejection fraction (EFmrHF or EFrHF, i.e., EF ≤ 49%) with or without peripheral vascular disease as confirmed by the cardiologists of the institutes [28]. Healthy subjects were defined as those with no obvious history of chronic disease such as severe hypertension, uncontrolled mild hypertension [29], other cardiovascular diseases, diabetes mellitus, organ disease, autoimmune diseases, cancer, anemia, psychiatric diseases or aliments of the lower extremities affecting exercise, and acute illnesses.

2.3. Measurements

2.3.1. Clinical Assessment Tests

The subjects used the oxygen-cost diagram (OCD) [30] to assess daily activities. They were asked to indicate a point on an OCD, a 100-mm-long vertical line with everyday activities listed alongside the line, above which breathlessness limited them. The distance from zero was measured and scored. The New York Heart Association functional classification (NYHAfc) and modified Medical Research Council (mMRC) scales were also used to grade the functional status of the cardiopulmonary participants [28,30]. The mMRC scale includes 5 grades from 0 indicating “I only get breathless with strenuous exercise” to 4 “I am too breathless to leave the house”.

2.3.2. Pulmonary Function Testing

FEV1, total lung capacity (TLC), and diffusing capacity for carbon monoxide (DLCO) were measured using spirometry and body plethysmography in accordance with the currently recommended standards.

2.3.3. Cardiopulmonary Exercise Testing (CPET)

Each subject completed a ramp-pattern exercise test from resting to unloading, and the limit of their tolerance. Work rate was selected at a rate of 5–20 watts/minute depending on their fitness so that they could complete the loaded exercise within 8–12 min. Their fitness was evaluated using an OCD scale, and the ramp slope was selected on the basis of their fitness [31]. The time for loaded exercise was 8.4 ± 1.7 min for all subjects. Oxygen uptake ( V . O2, mL/min), CO2 output ( V . CO2, mL/min), minute ventilation ( V . E), blood pressure, oxyhemoglobin saturation assessed by pulse oximetry (SPO2), blood pressure, and Borg dyspnea score were measured.

2.3.4. Near Infrared Spectroscopy (NIRS)

An OxiplexTSTM system (ISS, Champaign, IL, USA) was used to measure deoxygenated and oxygenated hemoglobin and intracellular myoglobin (HHb+HMb and HbO2+MbO2) [32,33]. Even though (Mb) is likely to contribute 60%–90% to the NIRS signals coming from skeletal muscles [34], for simplicity, we used HHb and HbO2 instead of HHb+HMb and HbO2+MbO2. The distance between the transmitter and receiver optodes of the NIRS system was 4 cm. NIRS is usually expressed by relative values instead of absolute values. However, the OxiplexTSTM system can provide absolute values of tissue saturation in real time [26,35], and it is therefore possible to explicitly compare the magnitudes of responses in tissue HHb, HbO2, the sum of both (total blood capacity, TOT), and tissue saturation or the tissue oxygenation index (the fraction of oxygenation and sum of the two laser diode wavelengths, SmO2, %). As TOT cannot be used to represent blood flow [36], we defined the sum of HHb and HbO2 as the total blood capacity, which included arterial, capillary, and venous blood volumes. A calibration block was used before each test as recommended by the manufacturer. The leg probe of the OxiplexTSTM system was positioned over the vastus lateralis muscle 10–12 cm above the knee, parallel to the major axis of the thigh [37], and the thoracic probe was positioned approximately at the sixth intercostal space along the anterior axillary line [38] to monitor the anterior serratus and intercostal muscles [39]. We selected the anterior serratus muscle because fatigue of this muscle is accompanied with diaphragmatic fatigue during incremental exercise [40] and during the latter stages of maximal exercise (75% of maximum V . O2 and more [41]), and becomes dominant in hyperventilation [42,43]. A piece of plastic wrap was used to prevent the lamp from becoming fogged by sweat during exercise. An elastic strap was used to secure the leg probe and adhesive tape was used to secure the chest probe. The sampling frequency of the fdNIRS device was set at 1 Hz. For simplicity, NIRS data were averaged and presented for the last 15 s of rest, unloaded pedaling and peak loaded exercise. Of note, at peak exercise, the nadir was used for variables that decreased compared to the baseline and the peak was used for variables that increased. These data were used for information on the dynamic balance between O2 supply (possibly also including O2 store with myoglobin and cytochrome c) and O2 demand. We did not record the respiratory compensation point or the anaerobic threshold, as they are difficult to identify and measure at a single location during incremental exercise [44,45].

2.4. Statistical Analysis

Data were summarized as mean ± standard deviation. The sample size was estimated to be at least 10 for each group when the population mean difference in SmO2 was 5.5 with a standard deviation for the normal and CHF groups of 4 and with a significance level of 0.05 and a power of 0.8 [46]. For each outcome variable, the comparisons were planned a priori. In the univariate analysis, p values were calculated by analysis of variance (ANOVA) with Tukey’s correction for multiple comparisons to compare means across the three groups. The paired t test was used to compare two related means between different time points. Fisher’s exact method was used in a contingency table analysis for categorical variables. Muscle mass is related to age, body height and weight [47,48,49], and muscle hypoxia is affected by hypoxemia. Thus, general linear models were used in comparison of the three groups (normal, COPD, CHF), adjusting for potential confounders such as age, body mass index, and SpO2 at each time point, respectively. For comparisons within different time points for the same variable, we did not adjust for other confounders as the measurements were from the same subject and the comparisons were planned a priori [5]. During loaded exercise, the HHb level is workload-related [35,42,50] and thus, the Hb variables were additionally corrected for peak workload. Pearson’s correlation coefficients were used to quantify the pair-wise relationships between NIRS data and the demographic, lung function and peak exercise variables. All statistical analyses were performed using SAS statistical software (9.4, SAS Institute Inc., Cary, NC, USA). Statistical significance was set at p < 0.05.

3. Results

3.1. Population Characteristics

A total of 175 subjects were screened and 134 subjects were retained for analysis after excluding 41 subjects (Figure 1 and Table 1). The subjects were allocated into three groups (Table 1). Differences in OCD, NYHAfc, and mMRC scores between the patients with COPD and CHF were insignificant (all p = NS). The etiologies of CHF are shown in Table 1. Differences in demographic data, symptom scores, resting lung function, exercise physiology, SPO2 and performance of peak exercise in the three groups are shown in Table 1 and Table 2.

3.2. Contrast of Leg Muscles to Ventilatory Muscles

In comparison to the leg muscles of all participants, the ventilatory muscles usually had lower HHb, HbO2, and TOT and higher SmO2 values at rest and during unloaded and loaded exercise (Figure 2). The lower value of SmO2 in the ventilatory muscles than in the leg muscles during loaded exercise only occurred in the CHF group (please see below and Figure 3).

3.3. Leg Muscles in the Three Groups

To better visualize the dynamic changes in oxygenation of leg and ventilatory musculatures for comparisons across the three groups, the same dataset as Figure 2 was used (Figure 3). At rest, the healthy group tended to have higher HbO2 and significantly higher SmO2 (p < 0.0001), whereas the COPD group tended to have higher HHb (p < 0.1) and the CHF group tended to have lower HbO2 (p < 0.1) and TOT (Figure 3, left panels). Across the three groups, scenarios in the Hb variables during unloaded and loaded exercise were the same as at rest. Unloaded exercise did not change HbO2 but decreased HHb, thereby decreasing TOT and increasing SmO2 in all subjects (Figure 3). Although unloaded exercise changed the four Hb variables, the directions and levels of change were similar across the three groups. Loaded exercise significantly increased HHb in all subjects (all p < 0.0001) but did not significantly change HbO2, thereby significantly increasing TOT and decreasing SmO2 (Figure 3). Although loaded exercise changed the four Hb variables, the directions and levels of change were similar across the three groups.

3.4. Ventilatory Muscles in the Three Groups

At rest, the healthy subjects had modestly higher or tended to have higher HbO2, TOT, and SmO2 (Figure 3, right panels, p < 0.1). Across the three groups, differences in the Hb variables during unloaded and loaded exercise were the same as at rest. Unloaded exercise did not change the four variables for all subjects, except that TOT and SmO2 were slightly increased in the COPD group (Figure 3). Loaded exercise significantly increased HHb (except the CHF group) and decreased HbO2 (all p < 0.05–0.0001), thereby slightly decreasing TOT (p < 0.1–0.001) and significantly decreasing SmO2 (p < 0.05–0.0001). The CHF group had significantly lower SmO2 than the COPD group at peak exercise (p < 0.01).

3.5. SmO2 Data at Peak Exercise versus Demographic, Lung Function and CPET Data

Nadir SmO2 levels obtained from the two musculatures had the best correlations with the demographic, lung function and CPET data at peak exercise compared to the other three Hb variables. For simplicity, only SmO2 was reported. Nadir SmO2 of the leg muscles was related to age (r = −0.36, Table 3), OCD (r = 0.30), maximal inspiratory pressure (MIP) %pred (r = 0.47), and some peak exercise variables, including heart rate (r = 0.30), V . E/maximal voluntary ventilation (MVV) ratio (r = −0.30), Borg score (r = −0.49), SPO2 (r = 0.37), and nadir V . E/ V . CO2 (r = −0.30). Nadir SmO2 of the ventilatory muscles was related to age (r = −0.30), OCD (r = 0.29), cigarette smoking (r = −0.26), MIP %pred (r = 0.56), and some peak exercise variables including heart rate (r = 0.29) and V . E/MVV ratio (r = −0.34).

4. Discussion

The important findings of this study are that the leg muscles of all participants had higher HHb, HbO2 and TOT but lower SmO2 than the ventilatory muscles throughout the tests. In addition, the healthy controls had higher levels of SmO2 and HbO2 in both muscles throughout the tests, whereas the COPD group had higher HHb levels and the CHF group had lower HbO2 levels, which is consistent with a previous report [51]. Unloaded exercise changed the four Hb variables of the leg muscles more prominently than those of the ventilatory muscles. Loaded exercise increased HHb but did not change HbO2, thereby increasing TOT and decreasing SmO2 in the leg muscles. However, loaded exercise conversely decreased HbO2 and TOT in the ventilatory muscles and decreased SmO2 to a lower level in the diseased subjects than in the healthy subjects (Figure 3, p < 0.01) and to a further lower level in the CHF group (p < 0.01). The correlation study revealed some factors that were detrimental and others beneficial to SmO2 and by interventions, the SmO2 might be improved (please see Section 4.5. Correlations). The findings of this study highlight the feasibility of using fdNIRS and the importance of measurements of muscle oxygenation and blood volume changes in addition to clinical assessment tools for patients with exertional dyspnea, and thus offer a critical reference for clinicians in the management of such patients with ventilatory muscle weakness as ventilatory muscle weakness may aggravate ventilation-perfusion mismatch during exercise [52].

4.1. Re-Definition of HHb, HbO2, TOT, and SmO2

Changes in HHb and HbO2 were reported to indicate oxidative metabolism [5], i.e., that HHb represents tissue oxygen consumption and HbO2 represents tissue oxygen perfusion or delivery, respectively. TOT was reported to indicate recruitment strategies of circulation [5], also called O2 diffusion capacity [44,53] or to be related to vessel conductance [54] and SmO2 was reported to indicate the balance between muscle oxygen supply and demand [55].
However, muscle metabolism or blood flow cannot be evaluated using NIRS without performing arterial or venous occlusion [17,56,57,58] because HbO2 and HHb levels reflect the instantaneous balance between muscular oxygen consumption and delivery and probably need to take into consideration O2 store in the tissue of interest. During unloaded leg exercise, the leg muscles are the most active muscles (at least compared to ventilatory muscles), despite the workload being “~zero” watts, and pump HHb blood into veins and thus decrease HHb but preserve HbO2 (due to “~zero” watts, i.e., very light workload), thereby decreasing TOT and increasing SmO2. Oxygen consumption and total blood flow during this time cannot be lower than those at rest, so that HHb is not only an indicator of oxygen consumption but also an indicator of venous blood that is pumped away (i.e., decrease in HHb signal) or stored if any (i.e., increase in HHb signal) and therefore, TOT cannot represent blood flow but blood capacity (or volumes) of the tissue of interest [36,44,53,54]. Mancini et al. [38] and Terakado et al. [38,59] used isosbestic points of 800 nm and 805 nm to indicate blood volume rather than using TOT. Hirai et al. defined O2 diffusion as “flux of O2 driven by O2 pressure differential between the capillary and the intramyocyte milieu operating against a finite O2 diffusing capacity” [13], which is quite different from the definitions reported in prior studies [44,53]. The difference between HbO2 and HHb represents the balance between oxygen supply and extraction, and it probably resembles the meaning of SmO2, although not mathematically [16,58]. Of note, Legrand et al. used the difference in the absorption between 730 and 850 nm to indicate muscle oxygenation [14], whereas Mancini et al. used the difference in absorption between 800 and 760 nm for hemoglobin oxygen saturation [38], Mancini et al. and Chuang et al. used the difference in absorption between 760 and 850 nm for muscle deoxygenation [18,37], and Terkado et al. and Watanabe et al. used HbO2 = x1ΔA780 + y1ΔA805 + z1ΔA830 and HHb = x2ΔA780 − y2ΔA805 − z2ΔA830 (x1,2, y1,2, z1,2, coefficients; ΔA, change in the absorbance) [54,59]. In addition, Lucero et al. reported HbO2 and HHb values without providing the formula using the wavelengths [57].

4.2. Leg Muscles Versus Ventilatory Muscles

Blood volume has been reported to be higher in leg muscles than in ventilatory muscles [17,59]. This may have caused a higher blood volume per unit of tissue of interest in the leg muscles than in the ventilatory muscles and thus, the systemically higher values of HbO2 and HHb and TOT in the leg muscles compared to the ventilatory muscles, which is compatible with a previous study [17]. However, SmO2 was higher in the ventilatory muscles than in the leg muscles in this study. We speculate that the high SmO2 in the ventilatory muscles may be related to type I/II ratio, capillary/muscle density or capillary/myofibril ratio. Aerobic muscle enzyme activities have been reported to be higher in the ventilatory muscles in patients with COPD and CHF, whereas some anaerobic muscle enzyme activities have been reported to be higher in the quadriceps femoris [1]. In contrast to the leg muscles, the ventilatory muscles do not change much during unloaded exercise as they are involved only when exercise progresses to >85% of peak V . O2 [44]. This might be different from the sternocleidomastoid muscle which usually demonstrates increased activity at 30% of maximal inspiratory pressure in patients with COPD [60].

4.3. Loaded Exercise-Leg Muscles

In the present study, the leg muscles had preserved HbO2 and increased TOT due to the increase in HHb in all participants during loaded exercise, which is consistent with a report by Vogiatzis et al., who used NIRS with the IGD method to study patients with COPD [22]. This suggests that the blood flow supply was adequate or maintained to an extent that oxidative metabolism or demand or consumption (i.e., HHb) increased to a larger extent. However, Reid et al. reported that HbO2 decreased in biceps in response to an incremental forearm contraction in patients with COPD [16].
In the present study, HHb reached a similar level under maximal exercise across the three groups despite the different physiological limitations and exercise loads. This suggests that the peak capability of skeletal muscle oxygen extraction was similar across the three groups at peak exercise with the heart rate/predicted heart rate ratio reaching a similar level (Table 2, p = 0.11), and that a unique decrease in SPO2 may contribute to the mechanism in patients with COPD (Table 2, p = 0.009). This is compatible with a previous study by Lanfranconi et al., who reported that during incremental exercise, changes in HHb at peak exercise and V . O2peak were lower in heart transplant recipients than in normal controls [49]. However, at lower exercise intensity in constant work rate exercise, they reported no difference in the kinetics of HHb between the two groups, despite the former having slower kinetics of V . O2 and heart rate [49]. The authors reported that the peak heart rate was 133.8 ± 3.8 b/min in patients aged 50.4 ± 2.6 years versus 173.0 ± 4.8 b/min in normal controls aged 47.3 ± 3.0 years; the heart rate stress level was estimated to be 79% versus 100%.
However, Katz et al. reported that in an invasive femoral venous blood study, patients with heart failure had higher oxygen extraction in leg muscles at peak exercise than healthy subjects [51]. Similarly, Zelt et al. reported that in patients with mild COPD, there was higher oxygen extraction in forearm muscles performing a continuous isometric handgrip squeeze at 20% of maximal voluntary contraction for 1.5 min compared to age-matched normal subjects [11]. We speculate that (1) the femoral vein and NIRS provide different information, as the former collects both superficial and deep leg veins whereas the latter collects the superficial microcirculation, and (2) all of the previous studies and the present study used different exercise protocols and different methods to calculate HbO2, HHb, and TOT, and measured different groups of muscles, and that all of these factors may have caused the difference in the results.

4.4. Loaded Exercise-Ventilatory Muscles

In the present study, in the ventilatory muscles, loaded exercise decreased both HbO2 and TOT unequally across the three groups, which is compatible with previous studies in patients with COPD and normal subjects [14,22], suggesting that blood flow to the ventilatory muscles did not match the need for oxidative metabolism. The healthy subjects had higher HbO2, TOT, and SmO2, whereas the CHF group had lower HbO2, TOT, and HHb, and the CHF group had the lowest SmO2 at peak exercise. We speculate that the CHF group had poor perfusion in the ventilatory muscles at peak exercise, which is compatible with previous reports [5,22,59]. Thus, this study does not support the metaboreflex or steal phenomenon of blood redistribution during heavy exercise [14,20,21,22,38,59]. This phenomenon has also not been supported in previous reports, as both blood volumes of ventilatory muscles and leg muscles decrease from the breakpoint of muscle oxygenation (i.e., ~74–88% of V . O2peak) to peak exercise [14,50]. In addition, molecular mechanisms of diaphragm muscle atrophy in patients with severe COPD have been reported to be downregulated in muscle-specific microRNA expressions and to be higher in histone deacetylase 4 and myocyte enhancer factor 2C protein levels [61]. Further studies are needed to investigate whether these findings are related to impaired peripheral oxygenation caused by chronic poor perfusion in ventilatory and leg muscles and whether they can be extrapolated to patients with CHF. In addition, molecular and NIRS studies on the mechanisms of muscle atrophy in both ventilatory and leg muscles are warranted.

4.5. Correlations

In the correlation study, aging, high ventilation demand/capacity ratio, exercise hyperventilation, and high dyspnea rating were detrimental to SmO2, whereas inspiratory muscle strength and high heart rate and SPO2 at peak exercise were beneficial to SmO2. Thus, reducing ventilation demand/capacity ratio, exercise hyperventilation, and high dyspnea rating with interventions such as exercise training may improve SmO2. On the other hand, improving inspiratory muscle strength and SpO2 and enhancing the capacity of heart rate increase by exercise training and breathing maneuvers with O2 breathing may also improve SmO2. Lastly, V . O2peak %predicted and peak work rate %predicted were not related to any of the four Hb variables of both musculatures in the present study (Table 3), compatible with a previous study [54]. This indicates that oxygen extraction (HHb) and the other three variables were not related to exercise capacity. However, changes in HHb at peak exercise in the leg muscles have been reported to be highly related to V . O2peak (r = 0.9, p < 0.0001) in patients with mitochondrial myopathy and McArdle’s disease [48]. In patients with mitochondrial myopathy and McArdle’s disease, myofibrils extract approximately 20% of the oxygen, whereas in normal controls, they extract approximately 70% [48]. In patients with heart failure or heart transplantation, myofibrils extract normal [49] or even higher amounts of oxygen [51].

4.6. Study Limitations

Age and body mass index were different across the three groups and thus, selection bias may have been introduced. The issue of choosing different exercise increments among the subjects during CPET could have affected the pattern of oxygenation/deoxygenation responses between the three groups and should be considered to be a limitation of the study. Combining the IGD technique and NIRS can improve measurements of the peripheral circulation [20,21,22]. Given that the present study cannot conclusively refute the steal phenomenon and that the IGD technique is sophisticated, studies using central hemodynamic response measurements with a thermodilution method combined with NIRS and IGD to investigate systemic cardiac output and local circulation of locomotor and ventilatory muscles during exercise are warranted to investigate the steal phenomenon [21,38,62]. Time intervals and levels of exercise intensity are also important when studying the steal phenomenon. Additionally, the potential mechanism(s) orchestrating the study results cannot be identified in the present study because cardiac output, systemic oxygen delivery, leg and ventilatory muscle blood flow and oxygen delivery, muscle mass morphological and structural assessments were not evaluated. Moreover, when a single probe is used on large muscles, the NIRS signals may not represent the whole musculature, as potential heterogeneity of tissue responses limits its capability [34]. The thickness of subcutaneous fat was not measured in the present study because it has been reported to be a minor factor as it is limited to <10 mm [63]. For direct comparisons of HHb, HbO2, and TOT between individuals when using fdNIRS, correcting for adipose tissue thickness (ATT) for these variables has been recommended [34]. In our previous report, the triceps skinfold thickness was 5.5–6.7 mm in patients with COPD with a body mass index ranging from 20.7 ± 2.3 to 22.7 ± 3.8 kg/m2 [64]. As thigh skinfold is correlated with body mass index [65], this issue is expected to be minor as most of our participants had a body mass index between 23.8 ± 3.0 and 26.3 ± 3.1 kg/m2. Previous studies have reported skinfolds at the sixth intercostal space and the anterior axillary line ranging from 6.7 ± 2.3 to 6.7 ± 4.6 mm, and a skinfold at the vastus lateralis muscle ranging from 8.6 ± 4.6 to 8.4 ± 2.9 mm in young subjects with a BMI of 21.7 to 23.7 kg/m2 [14,17], and 6.5 ± 1.0 mm in middle-aged normal subjects and heart transplant recipients with a BMI of 25.1 to 26.2 kg/m2 [49]. Although a reference was available to correct the NIRS signals after considering ATT, only seven male participants were included in their study, which raises concerns about its generalizability [66]. The cutaneous circulation may contribute to Hb NIRS signals in both muscles [67]; however, this contribution may be controversial. In normal subjects, at moderate intensity exercise and at maximal exercise, Anderson reported that total cutaneous blood flow decreased from 2 L/min to 1 L/min while total muscular blood flow increased from 12 L/min to 22 L/min [68]. To discriminate perfusive or diffusive defects as the mechanism of impaired oxygen transport [13], high-power time-resolved NIRS should be used. However, this equipment is still costly. Lastly, the sample size was small and further studies are needed with a larger number of participants. Despite these limitations, through careful interpretation and by not enrolling obese subjects, fdNIRS may still be useful to measure muscular metabolism and microcirculation.

5. Conclusions

This study differentiates the Hb oxygenation status of locomotor and ventilatory muscles between healthy and diseased subjects using frequency domain NIRS which can yield absolute values. The status of Hb oxygenation was different in different musculatures, and changes in oxygenation and SmO2 in response to loaded exercise between locomotor and ventilatory muscles were related to the type of disease. When performing peak exercise, more attention should be paid to ventilatory muscles in patients with cardiopulmonary diseases, especially those with CHF.

6. Future Perspectives

To better understand the potential mechanisms orchestrating dynamic muscle oxygenation in different types of diseases, directly measuring cardiac output, systemic oxygen delivery, leg and ventilatory muscle blood flow and oxygen delivery, and muscle mass morphological and structural changes and molecular mechanisms of muscle atrophy concomitantly with tissue monitoring with near infrared spectroscopy is warranted. This may be also suitable for interpreting the effects of pharmacological and non-pharmacological interventions in patients with exertional dyspnea.

Author Contributions

M.-L.C.: initiated and designed the study, analyzed and interpreted the data, wrote the manuscript, and approved the version to be published. I.-F.L.: statistical analysis, revised the manuscript critically for important intellectual content, and approved the version to be published. M.-J.H.: reviewed and interpreted the data, revised the manuscript critically for important intellectual content, and approved the version to be published.

Funding

This study was supported in part by the Minister of Science and technology, Taiwan (MOST 106-2314-B-040-025).

Acknowledgments

The authors would like to thank the Ministry of Science and Technology, Taiwan, for the support in part of the study (MOST 106-2314-B-040-025).

Conflicts of Interest

The authors declare no competing financial interests.

References

  1. Gosker, H.R.; Wouters, E.F.; van der Vusse, G.J.; Schols, A. Skeletal muscle dysfunction in chronic obstructive pulmonary disease and chronic heart failure: Underlying mechanisms and therapy perspectives. Am. J. Clin. Nutr. 2000, 71, 1033–1047. [Google Scholar] [CrossRef] [PubMed]
  2. Aliverti, A.; Macklem, P.T. Last Word on Point: Counterpoint: The major limitation to exercise performance in COPD is 1) inadequate energy supply to the respiratory and locomotor muscles, 2) lower limb muscle dysfunction, 3) dynamic hyperinflation. J. Appl. Physiol. 2008, 105, 763. [Google Scholar] [CrossRef] [PubMed]
  3. Debigare, R.; Maltais, F. The major limitation to exercise performance in COPD is lower limb muscle dysfunction. J. Appl. Physiol. 2008, 105, 751–753. [Google Scholar] [CrossRef] [PubMed]
  4. Okita, K. Skeletal muscle metabolism during exercise in chronic heart failure. In Cardiopulmonary Exercise Testing and Cardiovascular Health; Wasserman, K., Ed.; Wiley-Blackwell: Hoboken, NJ, USA, 2005; pp. 27–39. [Google Scholar]
  5. Tanaka, T.; Basoudan, N.; Melo, L.T.; Wickerson, L.; Brochard, L.J.; Goligher, E.C.; Reid, W.D. Deoxygenation of inspiratory muscles during cycling, hyperpnoea and loaded breathing in health and disease: A systematic review. Clin. Physiol. Funct. Imaging 2018, 38, 554–565. [Google Scholar] [CrossRef] [PubMed]
  6. Doucet, M.; Dubé, A.J.; Oanisse, D.R.; Debigaré, R.; Michaud, A.; Paré, M.È.; Vaillancourt, R.; Fréchette, E.; Maltais, F. Atrophy and hypertrophy signalling of the quadriceps and diaphragm in COPD. Thorax 2010, 65, 963–970. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  7. McKenzie, D.K.; Butler, J.E.; Gandevia, S.C. Respiratory muscle function and activation in chronic obstructive pulmonary disease. J. Appl. Physiol. 2009, 107, 621–629. [Google Scholar] [CrossRef] [Green Version]
  8. Puente-Maestu, L.; Lázaro, A.; Humanes, B. Metabolic derangements in COPD muscle dysfunction. J. Appl. Physiol. 2013, 114, 1282–1290. [Google Scholar] [CrossRef] [Green Version]
  9. Gosker, H.R.; van Mameren, H.; van Dijk, P.J.; Engelen, M.P.; van der Vusse, G.J.; Wouters, E.F.; Schols, A.M. Skeletal muscle fibre-type shifting and metabolic profile in patients with chronic obstructive pulmonary disease. Eur. Respir. J. 2002, 19, 617–625. [Google Scholar] [CrossRef]
  10. Hayot, M.; Rodriguez, J.; Vernus, B.; Carnac, G.; Jean, E.; Allen, D.; Goret, L.; Obert, P.; Candau, R.; Bonnieu, A. Myostatin up-regulation is associated with the skeletal muscle response to hypoxic stimuli. Mol. Cell Endocrinol. 2011, 332, 38–47. [Google Scholar] [CrossRef]
  11. Zelt, J.T.; Jones, J.H.; Hirai, D.M.; King, T.J.; Berton, D.C.; Pyke, K.E.; O’Donnell, D.E.; Neder, J.A. Systemic vascular dysfunction is associated with emphysema burden in mild COPD. Respir. Med. 2018, 136, 29–36. [Google Scholar] [CrossRef] [Green Version]
  12. Ribeiro, F.; Thériault, M.E.; Debigaré, R.; Maltais, F. Should all patients with COPD be exercise trained? J. Appl. Physiol. 2013, 114, 1300–1308. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  13. Hirai, D.M.; Much, T.I.; Poole, D.C. Exercise training in chronic heart failure: Improving skeletal muscle O2 transport and utilization. Am. J. Physiol. Heart Circ. Physiol. 2015, 309, H1419–H1439. [Google Scholar] [CrossRef] [PubMed]
  14. Legrand, R.; Marles, A.; Prieur, F.; Lazzari, S.; Blondel, N.; Mucci, P. Related trends in locomotor and respiratory muscle oxygenation during exercise. Med. Sci. Sports Exerc. 2007, 39, 91–100. [Google Scholar] [CrossRef] [PubMed]
  15. Mezzani, A.; Grassi, B.; Jones, A.M.; Giordano, A.; Corrà, U.; Porcelli, S.; Della Bella, S.; Taddeo, A.; Giannuzzi, P. Speeding of pulmonary VO2 on-kinetics by light-to-moderate-intensity aerobic exercise training in chronic heart failure: Clinical and pathophysiological correlates. Int. J. Cardiol. 2013, 167, 2189–2195. [Google Scholar] [CrossRef] [PubMed]
  16. Reid, W.D.; Sheel, A.W.; Shadgan, B.; Garland, S.J.; Road, J.D. Recruitment and Deoxygenation of Selected Respiratory and Skeletal Muscles During Incremental Loading in Stable COPD Patients. J. Cardiopulm. Rehabil. Prev. 2016, 36, 279–287. [Google Scholar] [CrossRef] [PubMed]
  17. Turner, L.A.; Tecklenburg-Lund, S.; Chapman, R.F.; Stager, J.M.; Duke, J.W.; Mickleborough, T.D. Inspiratory loading and limb locomotor and respiratory muscle deoxygenation during cycling exercise. Respir. Physiol. Neurobiol. 2013, 185, 506–514. [Google Scholar] [CrossRef]
  18. Mancini, D.M.; La Manca, J.; Donchez, L.; Henson, D.; Levine, S. The sensation of dyspnea during exercise is not determined by the work of breathing in patients with heart failure. J. Am. Coll. Cardiol. 1996, 28, 391–395. [Google Scholar] [CrossRef]
  19. Boushel, R.; Langberg, H.; Olesen, J.; Nowak, M.; Simonsen, L.; Bülow, J.; Kjaer, M. Regional blood flow during exercise in humans measured by near-infrared spectroscopy and indocyanine green. J. Appl. Physiol. 2000, 89, 1868–1878. [Google Scholar] [CrossRef]
  20. Guenette, J.A.; Vogiatzis, I.; Zakynthinos, S.; Athanasopoulos, D.; Koskolou, M.; Golemati, S.; Vasilopoulou, M.; Wagner, H.E.; Roussos, C.; Wagner, P.D.; et al. Human respiratory muscle blood flow measured by near-infrared spectroscopy and indocyanine green. J. Appl. Physiol. 2008, 104, 1202–1210. [Google Scholar] [CrossRef] [Green Version]
  21. Vogiatzis, I.; Athanasopoulos, D.; Boushel, R.; Guenette, J.A.; Koskolou, M.; Vasilopoulou, M.; Wagner, H.; Roussos, C.; Wagner, P.D.; Zakynthinos, S. Contribution of respiratory muscle blood flow to exercise-induced diaphragmatic fatigue in trained cyclists. J. Physiol. 2008, 586, 5575–5587. [Google Scholar] [CrossRef]
  22. Vogiatzis, I.; Athanasopoulos, D.; Habazettl, H.; Aliverti, A.; Louvaris, Z.; Cherouveim, E.; Wagner, H.; Roussos, C.; Wagner, P.D.; Zakynthinos, S. Intercostal muscle blood flow limitation during exercise in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2010, 182, 1105–1113. [Google Scholar] [CrossRef] [PubMed]
  23. Guenette, J.A.; Henderson, W.R.; Dominelli, P.B.; Querido, J.S.; Brasher, P.M.; Griesdale, D.E.; Boushel, R.; Sheel, A.W. Blood flow index using near-infrared spectroscopy and indocyanine green as a minimally invasive tool to assess respiratory muscle blood flow in humans. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2011, 300, R984–R992. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  24. Habazettl, H.; Athanasopoulos, D.; Kuebler, W.M.; Wagner, H.; Roussos, C.; Wagner, P.D.; Ungruhe, J.; Zakynthinos, S.; Vogiatzis, I. Near-infrared spectroscopy and indocyanine green derived blood flow index for noninvasive measurement of muscle perfusion during exercise. J. Appl. Physiol. 2010, 108, 962–967. [Google Scholar] [CrossRef] [PubMed]
  25. Louvaris, Z.; Habazettl, H.; Wagner, H.; Zakynthinos, S.; Wagner, P.D.; Vogiatzis, I. Near-infrared spectroscopy using indocyanine green dye for minimally invasive measurement of respiratory and leg muscle blood flow in patients with COPD. J. Appl. Physiol. 2018, 125, 947–959. [Google Scholar] [CrossRef] [PubMed]
  26. Wolf, M.; Ferrari, M.; Quaresima, V. Progress of near-infrared spectroscopy and topography for brain and muscle clinical applications. J. Biomed. Opt. 2007, 12, 062104. [Google Scholar] [PubMed]
  27. GOLD COPD. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. Available online: https://goldcopd.org/wp-content/uploads/2018/11/GOLD-2019-POCKET-GUIDE-FINAL_WMS.pdf (accessed on 6 January 2019).
  28. Ponikowski, P.; Voors, A.A.; Anker, S.D.; Bueno, H.; Cleland, J.G.F.; Coats, A.J.S.; Falk, V.; González-Juanatey, J.R.; Harjola, V.P.; Jankowska, E.A.; et al. 016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur. Heart J. 2016, 37, 2129–2200. [Google Scholar]
  29. James, P.A.; Oparil, S.; Carter, B.L.; Cushman, W.C.; Dennison-Himmelfarb, C.; Handler, J.; Lackland, D.T.; LeFevre, M.L.; MacKenzie, T.D.; Ogedegbe, O.; et al. 2014 evidence-based guideline for the management of high blood pressure in adults. report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 2014, 311, 507–520. [Google Scholar] [CrossRef]
  30. Mahler, D.A. Clinical measurement of dyspnea. In Dyspnea, 1st ed.; Futura Publishing: Leander, TX, USA, 1990; pp. 75–126. [Google Scholar]
  31. Chuang, M.L.; Lee, C.H.; Lin, I.F. Using the oxygen-cost diagram in ramp-slope selection for dyspneic patients. Intern. Med. 2010, 49, 1325–1332. [Google Scholar] [CrossRef]
  32. Jobsis, F.F. Noninvasive, infrared monitoring of cerebral and myocardial oxygen sufficiency and circulatory parameters. Science 1977, 198, 1264–1267. [Google Scholar] [CrossRef]
  33. Millikan, G.A. The oxymeter, an instrument for measuring continuously the oxygen saturation of arterial blood in man. Rev. Sci. Instrum. 1942, 13, 434–444. [Google Scholar] [CrossRef]
  34. Barstow, T.J. Understanding near infrared spectroscopy and its application to skeletal muscle research. J. Appl. Physiol. 2019, 126, 1360–1376. [Google Scholar] [CrossRef] [PubMed]
  35. Franceschini, M.A.; Wallace, D.J.; Barbieri, B.; Fantini, S.; Mantulin, W.W.; Pratesi, S.; Donzelli, G.P.; Gratton, E. Optical study of the skeletal muscle during exercise with a second generation frequency-domain tissue oximeter. SPIE Proc. 1997, 2979, 807–814. [Google Scholar]
  36. Yu, G.; Durduran, T.; Lech, G.; Zhou, C.; Chance, B.; Mohler, E.R.; Yodh, A.G. Time-dependent blood flow and oxygenation in human skeletal muscles measured with noninvasive near-infrared diffuse optical spectroscopies. J. Biomed. Opt. 2005, 10, 024027. [Google Scholar] [CrossRef] [PubMed]
  37. Chuang, M.L.; Ting, H.; Otsuka, T.; Sun, X.G.; Chiu, F.Y.; Hansen, J.E.; Wasserman, K. Muscle deoxygenation as related to work rate. Med. Sci. Sports Exerc. 2002, 34, 1614–1623. [Google Scholar] [CrossRef] [PubMed]
  38. Mancini, D.M.; Ferraro, N.; Nazzaro, D.; Chance, B.; Wilson, J.R. Respiratory muscle deoxygenation during exercise in patients with heart failure demonstrated with near-infrared spectroscopy. J. Am. Coll. Cardiol. 1991, 18, 492–498. [Google Scholar] [CrossRef] [Green Version]
  39. Standring, S. Gray’s Anatomy: The Anatomical Basis of Clinical Practice; Elsevier: Amsterdam, The Netherland, 2015. [Google Scholar]
  40. Vilozni, D.; Bar-Yishay, E.; Beardsmore, C.S.; Shochina, M.; Wolf, E.; Godfrey, S. A non-invasive method for measuring inspiratory muscle fatigue during progressive isocapnic hyperventilation in man. Eur. J. Appl. Physiol. Occup. Physiol. 1987, 56, 433–439. [Google Scholar] [CrossRef] [PubMed]
  41. Wetter, T.J.; Harms, C.A.; Nelson, W.B.; Pegelow, D.F.; Dempsey, J.A. Influence of respiratory muscle work on VO(2) and leg blood flow during submaximal exercise. J. Appl. Physiol. 1999, 87, 643–651. [Google Scholar] [CrossRef]
  42. Agbangla, N.F.; Audiffren, M.; Albinet, C.T. Assessing muscular oxygenation during incremental exercise using near-infrared spectroscopy: Comparison of three different methods. Physiol. Res. 2017, 66, 979–985. [Google Scholar]
  43. Babcock, M.A.; Pegelow, D.F.; Harms, C.A.; Dempsey, J.A. Effects of respiratory muscle unloading on exercise-induced diaphragm fatigue. J. Appl. Physiol. 2002, 93, 201–206. [Google Scholar] [CrossRef] [Green Version]
  44. Boone, J.; Vandekerckhove, K.; Coomans, I.; Prieur, F.; Bourgois, J.G. An integrated view on the oxygenation responses to incremental exercise at the brain, the locomotor and respiratory muscles. Eur. J. Appl. Physiol. 2016, 116, 2085–2102. [Google Scholar] [CrossRef]
  45. Okushima, D.; Poole, D.C.; Rossiter, H.B.; Barstow, T.J.; Kondo, N.; Ohmae, E.; Koga, S. Muscle deoxygenation in the quadriceps during ramp incremental cycling: Deep vs. superficial heterogeneity. J. Appl. Physiol. 2015, 119, 1313–1319. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  46. Chow, S.-C.; Shao, J.; Wang, H. Sample Size Calculations in Clinical Research, 2nd ed.; Chapman & Hall/CRC: Boca Raton, FL, USA, 2008. [Google Scholar]
  47. Gallagher, D.; Visser, M.; De Meersman, R.E.; Sepulveda, D.; Baumgartner, R.N.; Pierson, R.N.; Harris, T.; Heymsfield, S.B. Appendicular skeletal muscle mass: Effects of age, gender, and ethnicity. J. Appl. Physiol. 1997, 83, 229–239. [Google Scholar] [CrossRef] [PubMed]
  48. Grassi, B.; Marzorati, M.; Lanfranconi, F.; Ferri, A.; Longaretti, M.; Stucchi, A.; Vago, P.; Marconi, C.; Morandi, L. Impaired oxygen extraction in metabolic myopathies: Detection and quantification by near-infrared spectroscopy. Muscle Nerve 2007, 35, 510–520. [Google Scholar] [CrossRef] [PubMed]
  49. Lanfranconi, F.; Borrelli, E.; Ferri, A.; Porcelli, S.; Maccherini, M.; Chiavarelli, M.; Grassi, B. Noninvasive evaluation of skeletal muscle oxidative metabolism after heart transplant. Med. Sci. Sports Exerc. 2006, 38, 1374–1383. [Google Scholar] [CrossRef] [PubMed]
  50. Boone, J.; Barstow, T.J.; Celie, B.; Prieur, F.; Bourgois, J.G. The interrelationship between muscle oxygenation, muscle activation, and pulmonary oxygen uptake to incremental ramp exercise: Influence of aerobic fitness. Appl. Physiol. Nutr. Metab. 2016, 41, 55–62. [Google Scholar] [CrossRef] [PubMed]
  51. Katz, S.D.; Maskin, C.; Jondeau, G.; Cocke, T.; Berkowitz, R.; LeJemtel, T. Near-maximal fractional oxygen extraction by active skeletal muscle in patients with chronic heart failure. J. Appl. Physiol. 2015, 88, 2138–2142. [Google Scholar] [CrossRef] [PubMed]
  52. Hamazaki, N.; Masuda, T.; Kamiya, K.; Matsuzawa, R.; Nozaki, K.; Maekawa, E.; Noda, C.; Yamaoka-Tojo, M.; Ako, J. Respiratory muscle weakness increases dead-space ventilation ratio aggravating ventilation-perfusion mismatch during exercise in patients with chronic heart failure. Respirology 2019, 24, 154–161. [Google Scholar] [CrossRef]
  53. Davis, M.L.; Barstow, T.J. Estimated contribution of hemoglobin and myoglobin to near infrared spectroscopy. Respir. Physiol. Neurobiol. 2013, 186, 180–187. [Google Scholar] [CrossRef] [Green Version]
  54. Watanabe, S.; Ishii, C.; Takeyasu, N.; Ajisaka, R.; Nishina, H.; Morimoto, T.; Sakamoto, K.; Eda, K.; Ishiyama, M.; Saito, T.; et al. Assessing muscle vasodilation using near-infrared spectroscopy in cardiac patients. Jpn. Circ. J. 2005, 69, 802–814. [Google Scholar] [CrossRef]
  55. DeLorey, D.S.; Kowalchuk, J.M.; Paterson, D.H. Relationship between pulmonary O2 uptake kinetics and muscle deoxygenation during moderate-intensity exercise. J. Appl. Physiol. 2003, 95, 113–120. [Google Scholar] [CrossRef]
  56. Hamaoka, T.; McCully, K.K.; Quaresima, V.; Yamamoto, K.; Chance, B. Near-infrared spectroscopy/imaging for monitoring muscle oxygenation and oxidative metabolism in healthy and diseased humans. J. Biomed. Opt. 2007, 12, 062105. [Google Scholar] [CrossRef] [PubMed]
  57. Lucero, A.A.; Addae, G.; Lawrence, W.; Neway, B.; Credeur, D.P.; Faulkner, J.; Rowlands, D.; Stoner, L. Reliability of muscle blood flow and oxygen consumption response from exercise using near-infrared spectroscopy. Exp. Physiol. 2018, 103, 90–100. [Google Scholar] [CrossRef] [PubMed]
  58. Van Beekvelt, M.C.; Colier, W.N.; Wevers, R.A.; Van Engelen, B.G. Performance of near-infrared spectroscopy in measuring local O2 consumption and blood flow in skeletal muscle. J. Appl. Physiol. 2001, 90, 511–519. [Google Scholar] [CrossRef] [PubMed]
  59. Terakado, S.; Takeuchi, T.; Miura, T.; Sato, H.; Nishioka, N.; Fujieda, Y.; Kobayashi, R.; Ibukiyama, C. Early occurrence of respiratory muscle deoxygenation assessed by near-infrared spectroscopy during leg exercise in patients with chronic heart failure. Jpn. Circ. J. 1999, 63, 97–103. [Google Scholar] [CrossRef] [PubMed]
  60. De Troyer, A.; Peche, R.; Yernault, J.C.; Estenne, M. Neck muscle activity in patients with severe chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 1994, 150, 41–47. [Google Scholar] [CrossRef] [PubMed]
  61. Puig-Vilanova, E.; Aguiló, R.; Rodríguez-Fuster, A.; Martínez-Llorens, J.; Gea, J.; Barreiro, E. Epigenetic mechanisms in respiratory muscle dysfunction of patients with chronic obstructive pulmonary disease. PLoS ONE 2014, 9, e111514. [Google Scholar] [CrossRef] [PubMed]
  62. Miller, J.D.; Hemauer, S.J.; Smith, C.A.; Stickland, M.K.; Dempsey, J.A. Expiratory threshold loading impairs cardiovascular function in health and chronic heart failure during submaximal exercise. J. Appl. Physiol. 2006, 101, 213–227. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  63. Colier, W.N.; Meeuwsen, I.B.; Degens, H.; Oeseburg, B. Determination of oxygen consumption in muscle during exercise using near infrared spectroscopy. Acta Anaesthesiol. Scand. 1995, 39, 151–155. [Google Scholar] [CrossRef]
  64. Chuang, M.L.; Lin, I.F. Clinical characteristics and lung function in chronic obstructive pulmonary disease complicated with impaired peripheral oxygenation. Intern. Emerg. Med. 2014, 9, 633–640. [Google Scholar] [CrossRef]
  65. Ducimetiere, P.; Richard, J.L. The relationship between subsets of anthropometric upper versus lower body measurements and coronary heart disease risk in middle-aged men. The Paris Prospective Study. I. Int. J. Obes. 1989, 13, 111–121. [Google Scholar]
  66. Craig, J.C.; Broxterman, R.M.; Wilcox, S.L.; Chen, C.; Barstow, T.J. Effect of adipose tissue thickness, muscle site, and sex on near-infrared spectroscopy derived total-[hemoglobin + myoglobin]. J. Appl. Physiol. 2017, 123, 1571–1578. [Google Scholar] [CrossRef] [PubMed]
  67. Grassi, B.; Pogliaghi, S.; Rampichini, S.; Quaresima, V.; Ferrari, M.; Marconi, C.; Cerretelli, P. Muscle oxygenation and pulmonary gas exchange kinetics during cycling exercise on-transitions in humans. J. Appl. Physiol. 2003, 95, 149–158. [Google Scholar] [CrossRef] [PubMed]
  68. Anderson, K.L. The Cardiovascular System in Exercise; Academic Press: New York, NY, USA, 1968. [Google Scholar]
Figure 1. An image of flow diagram. A total of 175 subjects were screened and 134 patients were enrolled and analyzed. Follow-up was not applicable in this study.
Figure 1. An image of flow diagram. A total of 175 subjects were screened and 134 patients were enrolled and analyzed. Follow-up was not applicable in this study.
Jcm 08 01641 g001
Figure 2. Tissue deoxygenation (HHb, row (A)), oxygenation (HbO2, row (B)), total blood capacity (TOT, row (C)), and saturation (SmO2, row (D)) of leg muscles (solid symbol) and ventilatory muscles (open symbol) in response to incremental exercise in healthy subjects (Normal) and subjects with chronic obstructive pulmonary disease (COPD) and congestive heart failure (CHF). Paired t tests were used for comparison between two muscles at three stages of the exercise test, respectively: a p < 0.05, b p < 0.01, c p < 0.001, d p < 0.0001; paired t tests were used for comparisons of changes in variables between rest and unloaded exercise and between unloaded exercise and at peak (or nadir) exercise, respectively: # p < 0.1, * p < 0.05, ** p < 0.01, *** p < 0.001, + p < 0.0001.
Figure 2. Tissue deoxygenation (HHb, row (A)), oxygenation (HbO2, row (B)), total blood capacity (TOT, row (C)), and saturation (SmO2, row (D)) of leg muscles (solid symbol) and ventilatory muscles (open symbol) in response to incremental exercise in healthy subjects (Normal) and subjects with chronic obstructive pulmonary disease (COPD) and congestive heart failure (CHF). Paired t tests were used for comparison between two muscles at three stages of the exercise test, respectively: a p < 0.05, b p < 0.01, c p < 0.001, d p < 0.0001; paired t tests were used for comparisons of changes in variables between rest and unloaded exercise and between unloaded exercise and at peak (or nadir) exercise, respectively: # p < 0.1, * p < 0.05, ** p < 0.01, *** p < 0.001, + p < 0.0001.
Jcm 08 01641 g002
Figure 3. Tissue deoxygenation (HHb, row (A)), oxygenation (HbO2, row (B)), total blood capacity (TOT, row (C)), and saturation (SmO2, row (D)) of leg muscles (left panels, solid symbols) and ventilatory muscles (right panels, open symbols) in response to incremental exercise in healthy subjects (square symbol) and subjects with chronic obstructive pulmonary disease (COPD, circle symbol) and congestive heart failure (CHF, down triangle symbol). ANOVA was used for group comparisons at 3 stages of exercise, respectively: q p < 0.1, a p < 0.05, b p < 0.01, c p < 0.001, d p < 0.0001; Paired t tests were used for comparisons of changes in variables between rest and unloaded exercise and between unloaded exercise and at peak (or nadir) exercise, respectively: # p < 0.1, * p < 0.05, ** p < 0.01, *** p < 0.001, + p < 0.0001. Comparisons of variables between two groups of subjects, Arabic numbers 5 p < 0.1, 1 p < 0.05, 2 p < 0.01, 3 p < 0.001, 4 p < 0.0001.
Figure 3. Tissue deoxygenation (HHb, row (A)), oxygenation (HbO2, row (B)), total blood capacity (TOT, row (C)), and saturation (SmO2, row (D)) of leg muscles (left panels, solid symbols) and ventilatory muscles (right panels, open symbols) in response to incremental exercise in healthy subjects (square symbol) and subjects with chronic obstructive pulmonary disease (COPD, circle symbol) and congestive heart failure (CHF, down triangle symbol). ANOVA was used for group comparisons at 3 stages of exercise, respectively: q p < 0.1, a p < 0.05, b p < 0.01, c p < 0.001, d p < 0.0001; Paired t tests were used for comparisons of changes in variables between rest and unloaded exercise and between unloaded exercise and at peak (or nadir) exercise, respectively: # p < 0.1, * p < 0.05, ** p < 0.01, *** p < 0.001, + p < 0.0001. Comparisons of variables between two groups of subjects, Arabic numbers 5 p < 0.1, 1 p < 0.05, 2 p < 0.01, 3 p < 0.001, 4 p < 0.0001.
Jcm 08 01641 g003
Table 1. Demographic data, symptom scores, lung function and oxyhemoglobin saturation measured with pulse oximetry (SPO2) and oxygen uptake (VO2) at rest.
Table 1. Demographic data, symptom scores, lung function and oxyhemoglobin saturation measured with pulse oximetry (SPO2) and oxygen uptake (VO2) at rest.
GroupNormalCOPDCHFANOVA
meanSDmeanSDmeanSDp Value
n = 13437 77 20
Age, years54.517.566.411.152.112.6<0.0001
Gender, M/F33/4 70/7 19/1 0.76
Body mass index, kg/cm223.83.024.03.726.33.1<0.05
Oxygen-cost diagram, cm8.61.27.01.27.61<0.0001
NYHAfc, I, II, III (%)-37.9, 51.7, 10.347.1, 52.9, 00.58
mMRC, 0, 1, 2 (%)-41.4, 48.3, 10.370.6, 29.4, 00.14
Cigarette, pack⋅year4.817.55833.231.826<0.0001
Co-morbidity, Yes/No
Hypertension, n =4/36 *18/73 *11/20<0.01
Diabetes mellitus, n =1/36 *6/73 *1/200.57
Lung function and others
FVC %predicted, %961276218814<0.0001
FEV1%predicted, %971059228814<0.0001
FEV1/FVC ratio, %8175915825<0.0001
Ejection fraction , %----447NA
V . O2, %predicted, %175228186<0.01
SPO2, %971963971<0.001
COPD: chronic obstructive pulmonary disease, CHF: congestive heart failure. FVC: forced expired capacity, NYHAfc: New York Heart Association functional classification, mMRC: modified Medical Research Council, FEV1: forced expired volume in one second, * missing one and four subjects, respectively. Participants with CHF included 1 subject with ventricular septal defect, 2 subjects waiting for heart transplantations, 3 subjects with decompensated cardiomyopathy, 13 subjects with coronary artery disease, and 1 subject with hypertensive cardiovascular disease. Ejection fraction of the left ventricle using 2-dimensional echocardiography.
Table 2. Cardiopulmonary exercise test at peak exercise.
Table 2. Cardiopulmonary exercise test at peak exercise.
GroupNormalCOPDCHFANOVA
meanSDmeanSDmeanSDp Value
Workload, WR, watt144328740116280.0002
WR, watt% predicted, (%p), %10726782781270.42
Respiratory exchange ratio1.110.161.110.161.170.130.62
Oxygen uptake, V . O2 %p, %818682260160.07
V . O2, mL/min/kg30.4417.66.318.42.6<0.0001
V . O2_anaerobic threshold% max, %48849937 110.07
Cardiac frequency, fc, %p, %91584984150.11
V . O2/fc, mL/beat11293820.09
Systolic blood pressure, mm Hg1931717522150300.008
Diastolic blood pressure, mm Hg805861287210.82
Minute ventilation, V . E, L/min59.412.543.71761.718.90.002
Breathing frequency, b/min3263774380.01
Tidal volume, VT, L1.880.360.980.451.320.36<0.0001
VT peak/vital capacity0.50.060.470.10.450.090.46
V . E/maximum voluntary ventilation0.450.110.750.220.560.120.0001
V . E/CO2 output30.1537.15.937.73.90.002
SPO2, %94.6492.94.598.31.10.009
Borg dyspnea at peakNANA6.11.54.81.30.05
COPD: chronic obstructive pulmonary disease, CHF: congestive heart failure, SPO2: oxyhemoglobin saturation measured with pulse oximetry.
Table 3. Correlation coefficient (r) of oxygenation saturation of muscles at peak exercise with demographics, lung function and peak/nadir exercise in all subjects.
Table 3. Correlation coefficient (r) of oxygenation saturation of muscles at peak exercise with demographics, lung function and peak/nadir exercise in all subjects.
DemographicsVastus Lateralis (r)Serratus Anterior (r)
Age0.36 **0.30 *
OCD0.30 *0.29 *
Cigarette−0.130.26 *
BMI0.21 0.23
Lung function
MIP%0.470.56††
MEP%0.070.14
FVC%−0.03−0.13
FEV1%0.120.11
FEV1/FVC0.24 0.11
Exercise
HR0.30 *0.29 *
Watt%−0.020.02
VO2%−0.080.03
VO2/HR0.010.13
dVO2/dWR0.070.05
VE%0.33 **0.34 **
VE/VCO20.30 *−0.21
Borg0.49 −0.15
SPO20.37 **0.04
VT/VC−0.09−0.13
Bf0.03−0.08
OCD: oxygen-cost diagram, Cigarette: in pack × years, BMI: body mass index, MIP: maximal inspiratory pressure, MEP: maximal expiratory pressure, FVC: forced vital capacity, FEV1: forced expired volume in one second, HR: heart rate, d: slope, VO2: oxygen uptake, VE: minute ventilation, WR: work rate, VCO2: ratio of VE and carbon dioxide output, SPO2: oxyhemoglobin measured by pulse oximetry, VT/VC: ratio of tidal volume and vital capacity, Bf: breathing frequency. The numbers in bold indicate p < 0.05. 0.05 < p < 0.1, * p < 0.05, ** p < 0.01, p < 0.001, †† p < 0.0001.

Share and Cite

MDPI and ACS Style

Chuang, M.-L.; Lin, I.-F.; Hsieh, M.-J. More Impaired Dynamic Ventilatory Muscle Oxygenation in Congestive Heart Failure than in Chronic Obstructive Pulmonary Disease. J. Clin. Med. 2019, 8, 1641. https://doi.org/10.3390/jcm8101641

AMA Style

Chuang M-L, Lin I-F, Hsieh M-J. More Impaired Dynamic Ventilatory Muscle Oxygenation in Congestive Heart Failure than in Chronic Obstructive Pulmonary Disease. Journal of Clinical Medicine. 2019; 8(10):1641. https://doi.org/10.3390/jcm8101641

Chicago/Turabian Style

Chuang, Ming-Lung, I-Feng Lin, and Meng-Jer Hsieh. 2019. "More Impaired Dynamic Ventilatory Muscle Oxygenation in Congestive Heart Failure than in Chronic Obstructive Pulmonary Disease" Journal of Clinical Medicine 8, no. 10: 1641. https://doi.org/10.3390/jcm8101641

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop